Effects of topical elk velvet antler on cutaneous wound healing in streptozotocin-induced diabetic rats

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 5, 2004, Pages 835-840

  Mikler, John R ^a   Theoret, Christine L ^b   Haigh, Jerry C ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ELK VELVET ANTLER EXTRACT; GROWTH FACTOR; LUBRICATING AGENT; MUKO; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CHEMICAL INTERACTION; CONTROLLED STUDY; DIAGNOSTIC KIT; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST; SKIN INJURY; STREPTOZOCIN DIABETES; WOUND CLOSURE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GROWTH SUBSTANCES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE EXTRACTS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 8644235976     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2004.10.835     Document Type: Article

References (26)

1. Berger AC, Feldman AL, Grant MF, Kruger EA, Sim BK, Hewitt S, Figg WD, Alexander HR, Libutti SK. The angiogenexis inhibitor, endostatin, does not affect murine cutaneous wound healing. J Surg Res 2000;91:26-31.
2. Bitar MS, Labbad ZN. Transforming growth factor-beta and insulin like growth factor-1 in relation to diabetes-induced impairment of wound healing. J. Surg. Res 1996;61:113-119.
3. Brigham PA, McLoughlin E. Burn incidence and medical care use in the United States: Estimate, trends and data sources. J. Burn Care Rehabil 1996;17:95-107.
4. Chesnoy S, Lee PY, Huang L. Intradermal injection of transforming growth factor-beta1 gene enhances wound healing in genetically diabetic mice. Pharm Res 2003;20:345-350.
5. Cohen MA, Eaglestein WH. Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Dermatol 2001;45:857-862.
6. Davidson A. Velvet Antler, Nature's Superior Tonic. Sheffield, MA: Safe Goods, 2000.
7. Fahey TJ, Sadaty A, Jones WG. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991;50:308-315.
8. Frank S, Madlener M, Werner S. Transforming growth factors, beta1, 2 and 3 and their receptors are differently regulated during normal and impaired wound healing. J Biol Chem 1996;271:10188-10193.
9. Gross RJ. Future directions in antler research. Anatom Res 1995;241:291-302.
10. Huo Y, Schirf VR, Winters WD. The differential expression of NGF-like substance from fresh pilose antler of Cervux nippon Temminck. Biomed Sci Instrument 1997;33:541-543.
11. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest 1969;48:2129-2139.
12. Ko KM, Yip TT, Tsao SW, Kong YC, Fennessy P, Belew MC, Porath J. Epidermal growth factor from deer (Cervus elaphus) submaxillary gland and velvet antler. Gen Comp Endocrinol 1986;63:431-440.
13. Lange-Asschenfeldt B, Velasco P, Streit M, Hawighorst T, Pike SE, Tosato G, Detmar M. The angiogenesis inhibitor vasostatin does not impair wound healing at tumour-inhibiting doses. J Investig Dermatol 2001;117:1036-1041.
14. Lowry OH, Rosebrough HJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-269.
15. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A, Matsumoto M, Konno K, Ushlo H, Matsuda K. Role of nerve growth factor in cutaneous wound healing: Accelerating effects in normal and healing impaired diabetic mice. J Exp Med 1998;187:297-306.
16. Moulin V, Lawny F, Barritault D, Caruelle JP. Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol 1998;44:961-971.
17. Nagy A, Nagashima H, Cha S, Oxford GE, Zelles T, Peck AB, Humphreys-Beher MG. Reduced oral wound healing in the NOD mouse model for type I autoimmune diabetes and its reversal by epidermal growth factor supplementation. Diabetes 2001;50:2100-2104.
18. Nanney LB, Wamil BD, Whitsitt J, Cardwell NL, Davidson JM, Yan HP, Hellerqvist CG. CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism. Angiogenesis 2001;4:61-70.
19. Pierce GF, Mustoe TA. Pharmacological enhancement of wound healing. Ann Rev Med 1995;46:467-481.
20. Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Rep Regen 1999;7:362-374.
21. Singer AJ, Clark RAF. Cutaneous wound healing. New Engl J Med 1999;341:738-746.
22. Sunwoo HH, Nakano T, Sim JS. Effect of water-soluble extract from antler of wapiti on the growth of fibroblasts. Can J Anim Sci 1997;77:343-345.
23. Sunwoo HH, Nakano T, Sim JS. Isolation and characterization of proteoglycans from growing antlers of wapiti (Cervus elaphus). Comp Biochem Physiol B Biochem Mol Biol 1998;121:437-442.
24. Theoret CL, Barber SM, Moyana TN, and Gordon JR. Expression of transforming growth factor β1, β3 and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax. Vet Surg 2001;30:269-277.
25. Wieman TJ, Smiell JM, and Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with nonhealing diabetic ulcers: A phase III randomised, placebo-controlled, double-blind study. Diabetes Care 1998;21:822-827.
26. Zhao QC, Kiyohara H, Nagai T, Yamada H. Structure of the complement-activating proteoglycan from the pilose antler of Cervus nippon Temminck. Carbohydr Res 1992;230:361-372.